Carson Wealth (CWM LLC)
MNPR icon

Carson Wealth (CWM LLC)’s Monopar Therapeutics MNPR Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio MNPR Stock Details MNPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$822 Buy
15
+10
+200% +$604 ﹤0.01% 5422
2025
Q4 		$0 Hold
5
– – ﹤0.01% 5532
2025
Q3 		$0 Buy
+5
New +$224 ﹤0.01% 5434

Other funds holding MNPR

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Carson Wealth (CWM LLC)'s MNPR Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Monopar Therapeutics (MNPR) stake by 200% in Q1 2026, buying an estimated $604 and bringing the position to 15 shares worth $822. The position accounts for ﹤0.01% of the portfolio, ranked #5422.

Carson Wealth (CWM LLC) first reported a position in MNPR in Q3 2025 and has held it in 3 quarters since. 82 funds tracked by Wall St. Rank hold MNPR as of Q1 2026.

  • Carson Wealth (CWM LLC) held 15 shares of Monopar Therapeutics worth $822 as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 10 Monopar Therapeutics shares in Q1 2026, an estimated $604.
  • Monopar Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5422 holding.
  • Carson Wealth (CWM LLC) first reported a position in Monopar Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 82 funds tracked by Wall St. Rank held Monopar Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.